Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eyra Ortíz-Pérez"'
Autor:
Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia, Timoteo Delgado-Maldonado, Lenci K. Vázquez-Jiménez, Gabriel López-Velázquez, José Ignacio de la Mora-de la Mora, Sebastian Pacheco-Gutierrez, Laura Chino-Ríos, Diego Arias, Adriana Moreno-Rodríguez, Alma Paz-González, Eyra Ortíz-Pérez, Gildardo Rivera
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 39, Iss 1 (2024)
In this study, n-butyl and iso-butyl quinoxaline-7-carboxylate-1,4-di-N-oxide derivatives were evaluated in vitro against Giardia lamblia (G. lamblia), Trichomonas vaginalis (T. vaginalis), and Entamoeba histolytica (E. histolytica). The potential me
Externí odkaz:
https://doaj.org/article/cab2205556724a4d8d420c06e12456ca
Autor:
Alma D. Paz-González, Ana V. Martínez-Vázquez, Eyrá Ortiz-Perez, Carlos Ramírez-Martínez, Edgar E. Lara-Ramírez, Karina Juárez-Rendón, Virgilio Bocanegra-García, Karina Vázquez, Gildardo Rivera
Publikováno v:
CyTA - Journal of Food, Vol 22, Iss 1 (2024)
In this study, the aim was to identify and quantify antibiotic residues in pork meat samples of supermarkets and butcher shops of two main cities in northeast Mexico, using Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS). The resu
Externí odkaz:
https://doaj.org/article/e23c4a6304844a69a6ed416a0159e733
Autor:
Lenci K. Vázquez-Jiménez, Gildardo Rivera, Alfredo Juárez-Saldivar, Jessica L. Ortega-Balleza, Eyra Ortiz-Pérez, Elena Jaime-Sánchez, Alma Paz-González, Edgar E. Lara-Ramírez
Publikováno v:
Pharmaceutics, Vol 16, Iss 9, p 1165 (2024)
Cancer remains one of the leading diseases of mortality worldwide. Janus kinases 2/3 (JAK2/3) have been considered a drug target for the development of drugs to treat different types of cancer. JAK2/3 play a critical role in innate immunity, inflamma
Externí odkaz:
https://doaj.org/article/61af224434564478ab30f6bcbbb3e068
Autor:
Jessica L. Ortega-Balleza, Lenci K. Vázquez-Jiménez, Eyra Ortiz-Pérez, Guadalupe Avalos-Navarro, Alma D. Paz-González, Edgar E. Lara-Ramírez, Gildardo Rivera
Publikováno v:
Molecules, Vol 29, Iss 16, p 3944 (2024)
Currently, antimicrobial resistance (AMR) is a serious health problem in the world, mainly because of the rapid spread of multidrug-resistant (MDR) bacteria. These include bacteria that produce β-lactamases, which confer resistance to β-lactams, th
Externí odkaz:
https://doaj.org/article/e46544bb445d4660bf8873a34e83ac5c
Autor:
Luis D. González-Morales, Adriana Moreno-Rodríguez, Lenci K. Vázquez-Jiménez, Timoteo Delgado-Maldonado, Alfredo Juárez-Saldivar, Eyra Ortiz-Pérez, Alma D. Paz-Gonzalez, Edgar E. Lara-Ramírez, Lilian Yépez-Mulia, Patricia Meza, Gildardo Rivera
Publikováno v:
Pharmaceutics, Vol 15, Iss 8, p 2046 (2023)
Cutaneous leishmaniasis (CL) is a public health problem affecting more than 98 countries worldwide. No vaccine is available to prevent the disease, and available medical treatments cause serious side effects. Additionally, treatment failure and paras
Externí odkaz:
https://doaj.org/article/dc3210e9930940d1a45fbb9da827b40b
Autor:
Carlos Gaona-López, Lenci K. Vazquez-Jimenez, Alonzo Gonzalez-Gonzalez, Timoteo Delgado-Maldonado, Eyrá Ortiz-Pérez, Benjamín Nogueda-Torres, Adriana Moreno-Rodríguez, Karina Vázquez, Emma Saavedra, Gildardo Rivera
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 543 (2023)
Protozoan parasite diseases cause significant mortality and morbidity worldwide. Factors such as climate change, extreme poverty, migration, and a lack of life opportunities lead to the propagation of diseases classified as tropical or non-endemic. A
Externí odkaz:
https://doaj.org/article/23e0cdfe979f4e109e368c7335194dad
Autor:
Lenci K. Vázquez-Jiménez, Alfredo Juárez-Saldivar, Manuel J. Chan-Bacab, Timoteo Delgado-Maldonado, Luis D. González-Morales, Isidro Palos, Eyra Ortiz-Pérez, Edgar E. Lara-Ramírez, Esther Ramírez-Moreno, Gildardo Rivera
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 390 (2023)
Leishmania mexicana (L. mexicana) is a causal agent of cutaneous leishmaniasis (CL), a “Neglected disease”, for which the search for new drugs is a priority. Benzimidazole is a scaffold used to develop antiparasitic drugs; therefore, it is intere
Externí odkaz:
https://doaj.org/article/38989ea64191444d81e05e59e9ebd677
Autor:
Lenci K. Vázquez-Jiménez, Alfredo Juárez-Saldivar, Rogelio Gómez-Escobedo, Timoteo Delgado-Maldonado, Domingo Méndez-Álvarez, Isidro Palos, Debasish Bandyopadhyay, Carlos Gaona-Lopez, Eyra Ortiz-Pérez, Benjamín Nogueda-Torres, Esther Ramírez-Moreno, Gildardo Rivera
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 17, p 10047 (2022)
Trypanosoma cruzi (T. cruzi) is a parasite that affects humans and other mammals. T. cruzi depends on glycolysis as a source of adenosine triphosphate (ATP) supply, and triosephosphate isomerase (TIM) plays a key role in this metabolic pathway. This
Externí odkaz:
https://doaj.org/article/14a6768a0baf4c5db5524cc6cc5278ac